COM:CELYAD

Celyad Oncology

Stock

EUR

Last Close

0.46

02/05 08:16

Market Cap

11.14M

Beta: -

Volume Today

1.30K

Avg: -

Overview Financials API

Description

Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA ...Show More